Cortechs.ai | Precision Without the Pressure: Smarter Brain Tumor Monitoring

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Precision Without the Pressure: Smarter Brain Tumor Monitoring

In the management of brain tumors, precision is everything. From initial diagnosis through treatment monitoring and long-term follow-up, clinicians rely heavily on imaging to assess tumor size, location, and progression over time.

In many hospitals, imaging centers, and clinics today, tumor segmentation and volumetric analysis are still largely done manually—a time-consuming, subjective, and often inconsistent process. As the complexity of brain tumor treatment grows, so does the need for efficient, standardized imaging support.


The Challenges of Manual Tumor Segmentation

Manual segmentation—the process of outlining tumor boundaries by hand on MR images—has long been the standard in many settings. But it comes with major drawbacks:

  • Time-Intensive: Segmenting a brain tumor manually can take anywhere from 30 minutes to several hours, depending on the case complexity.

  • Inconsistency: Results can vary widely depending on the reader, leading to inter-reader variability that affects interpretation and planning.

  • Limited Comparability: Tracking tumor changes over time requires careful image comparison. Without standardized, quantitative data, this process is prone to error.

  • Workflow Burden: For busy radiology and oncology teams, manual segmentation adds a significant, often unscalable, workload.


Automated Segmentation for a Better Workflow

Automated segmentation and volumetric analysis help overcome these challenges by delivering:

  • Consistent, reproducible tumor segmentations
  • Quantitative data in a fraction of the time
  • Tools that support—not replace—clinical expertise

With NeuroQuant® Brain Tumor v2.0.0, an FDA-cleared solution is now available for the analysis of three of the most common tumor types: Gliomas, Meningiomas, and Brain Metastases.

By automating tumor segmentation and analysis, NQ BT supports treatment planning, longitudinal tracking, and clinical workflow—while reducing the manual burden on radiology and oncology teams.


NeuroQuant Brain Tumor Modules

Gliomas

Use Case: Longitudinal monitoring and treatment response

Gliomas are often diffuse and irregularly shaped, making them difficult to segment manually. Subtle changes over time are critical, and without quantitative tools, these can be hard to detect.

NQ BT Helps By:

  • Providing consistent 3D volumetric measurements across timepoints
  • Highlighting tumor burden and tissue type changes over time
  • Reducing subjectivity in evaluating progression or response

Meningiomas

Use Case: Surgical planning and surveillance

Though slow-growing, meningiomas can pose surgical challenges based on location. Accurate volume estimates are essential for making informed decisions.

NQ BT Helps By:

  • Quickly quantifying tumor volume to support treatment planning
  • Generating structured data for longitudinal surveillance
  • Supporting documentation of tumor stability or growth

Brain Metastases

Use Case: Radiation therapy planning and treatment monitoring

Patients with brain metastases often present with multiple lesions. Manually segmenting each is time-prohibitive and prone to errors.

NQ BT Helps By:

  • Rapidly identifying and segmenting multiple metastases
  • Providing RT STRUCT outputs to support radiation therapy workflows
  • Enhancing consistency in follow-up comparisons

Streamlined Clinical Integration

NeuroQuant Brain Tumor includes RT STRUCT output of segmentations—critical for integration into radiation therapy planning systems and PACS. This allows for:

  • Seamless import into existing systems
  • Support for multidisciplinary workflows
  • Reduced need for manual editing or conversions

A Smarter Way to Support Clinical Care

Automated segmentation and volumetric tracking aren’t meant to replace clinical judgment—they’re designed to empower it.

By improving consistency, enabling precise monitoring, and reducing manual workload, Cortechs.ai tools help clinicians make more informed decisions, faster.

In a world where time is limited and accuracy is essential, automation isn’t just helpful—it’s essential.

More Resources

10/15/2025

Sharper Screening, Smarter Biopsies: OnQ Prostate and the Next Step in Imaging

Read to learn how OnQ Prostate goes beyond existing solutions like DynaCAD and redefines biopsy precision

10/14/2025

Cortechs.ai Acquires ZepMed to Expand AI-Powered Neuroimaging Capabilities

This strategic acquisition strengthens Cortechs.ai’s position at the forefront of radiological innovation and expands its suite of best-in-class solutions

10/07/2025

Cortechs.ai Expands Partnership with Strategic Radiology to Advance Imaging Innovation Across Private Practices

Cortechs.ai and Strategic Radiology have now broadened their alliance to include Cortechs.ai’s full suite of imaging solutions.

10/06/2025

Clinical Performance of NeuroQuant: Transforming Brain MRI Analysis

NeuroQuant has consistently demonstrated strong clinical performance across multiple conditions, including Alzheimer’s , epilepsy, TBI, and MS.

10/02/2025

WEBINAR: Navigating Category III CPT Codes for Quantitative Imaging

Leveraging Compatible CPT Codes for NeuroQuant and OnQ Prostate

09/29/2025

The Role of NeuroQuant in Supporting Alzheimer’s Disease Care

NeuroQuant equips clinicians and researchers with data that can support earlier recognition of disease, track progression, and evaluate treatment efficacy.
Scroll to Top